Return to Normal View

Practitioner Profile - Virginia Board of Medicine

Unless otherwised indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Printer Friendly Version Printer Icon
 

Susan Percy Ivy, MD

LICENSE # 0101048926
  ivyp@ctep.nci.nih.gov

Issue Date: 12/30/1992
Expiration Date: 12/31/2024
Status: Current Active


Disclaimer: General
The following information contained in this database is provided from the records of the Board of Medicine.

The Department and the Board have taken measures to assure that the above information reflects information contained in records that it maintains consistent with its statutory responsibility to doctors of medicine, osteopathy, and podiatry.

The following information is required to be self-reported by licensees under penalty of law. This information is not verified by the Board. The Department and the Board have the authority to investigate reported inaccuracies in the displayed information and if warranted, seek correction and effect licensee compliance with the law and regulations governing the practitioner information system.

Required information provided by doctors:

Optional information doctors may choose to include:


The Board does not comprehensively verify the information required to be self-reported by doctors, and therefore does not accept responsibility for the accuracy of self-reported information. The Board conducts periodic random audits of profiles as an effort to improve the accuracy and timeliness of the information.

Please note that if a practitioner's license is not active, they are under no obligation to update their profile so the information contained in that profile may not be up-to-date.



Disclaimer: Malpractice Information

When considering malpractice paid claims data, please keep in mind:


Some studies have shown little correlation between the existence of a malpractice paid claims history and the practitioner's competence to provide care.

Malpractice paid claims histories tend to vary by specialty. Some specialties are more likely than others to be the subject of litigation.

Some doctors work primarily with high-risk patients. These doctors may have malpractice paid claims histories that are higher than average because they specialize in cases or patients who are at very high risk for problems.

Settlement of a claim may occur for a variety of reasons, which do not necessarily reflect negatively on the professional competence or conduct of the practitioner. A payment in settlement of a medical malpractice action or claim should not be construed as creating a presumption that medical malpractice has occurred.

The incident causing the malpractice paid claim may have happened years before a payment is finally made. Sometimes, it takes a long time for a malpractice lawsuit to move through the legal system.

Presentation of Required Data:

As of July 1, 2007, practitioners are required to report all paid claims over $10,000 in the last 10 years. For doctors practicing less than 10 years, the data covers their total years of practice.

To provide perspective regarding the reported data, the Board displays information about the paid claims experience of the practitioner's specialty along with the practitioner's history of paid claims. In reporting the data in this manner, each practitioner is seen relative to other practitioners in the specialty, rather than to all practitioners in all specialties.

Paid claims are not expressed in dollar amounts. Each paid claim has been analyzed and assigned to one of three statistical categories: below average, average, or above average. This analysis was made relative to the other claims in the specialty in which the claim occurred.

The information provided, in the manner provided, should offer perspective about this aspect of medical practice. You could miss an opportunity for high quality care by excluding a doctor based solely on the presence of a malpractice history. You may wish to discuss information provided in this report, and malpractice generally, with your doctor.



Primary Practice Address
Last Updated 3/31/2021
Department of Hematology/Oncology
Children's National Medical Center
111 Michigan Ave, NW
Washington, D. C. 20010
Phone: 202-884-3255

Location Details


Years in Active Clinical Practice
Last Updated 3/31/2021
Years in Active Clinical Practice Inside US/Canada: 30
Medicaid
Last Updated 3/31/2021
Participate in the Virginia Medicaid program
Is accepting new Virginia Medicaid patients
Virginia Hospital Affiliations
Last Updated 3/31/2021
Children's Hospital (admit)
Hospital Affiliations in States Other Than Virginia
Last Updated 3/31/2021
Medical, Osteopathic, or Podiatric School
Last Updated 3/31/2021
Grad School: Tulane University School Of Medicine - New Orleans LA
Year Completed: 1980
Medical, Osteopathic, or Podiatric Post Grad School
Last Updated 3/31/2021
General Surgery
Vanderbilt University School of Medicine
Nashville, Tennessee USA
Year Internship Completed: 1981


General Pediatrics
Tulane University School of Medicain
New Orleans, Louisana USA
Year Residency Completed: 1984


Pediatric Hematology/Oncology
National Cancer Institute, National Institutes of Health
Bethesda, Maryland USA
Year Fellowship Completed: 1989


Continuing Education
Last Updated 3/31/2021
Continuing Hours: 100
Since: 2019
Board Certification
Recognized by the American Board of Medical Specialties, Bureau of Osteopathic Specialists
and Boards of Certification, the American Board of Multiple Specialties in Podiatry, or Council on Podiatric Medical Education.
Last Updated 3/31/2021
Pediatrics
Year of Initial Certifications: 1986
Current Certification Expires: indefinite

Pediatrics: Pediatric Hematology-Oncology
Year of Initial Certifications: 1990
Current Certification Expires: 2015

Pediatrics: Pediatric Hematology-Oncology
Year of Initial Certifications: 1992
Current Certification Expires: 2011

Pediatrics: Pediatric Hematology-Oncology
Year of Initial Certifications: 2001
Current Certification Expires: 2002

Pediatrics: Pediatric Hematology-Oncology
Year of Initial Certifications: 2012
Current Certification Expires: 2014

Self-Designated Practice Areas
Last Updated 3/31/2021
Pediatrics: Hematology/Oncology
Insurance Plans/Managed Care Plans Accepted
Last Updated 3/31/2021
None Reported


Honors and Awards - Optional
Last Updated 3/31/2021
NIH Merit Award
National Cancer Institute
2001

NIH Merit Award 2014
NIH/NCI
2014

NIH Merit Award 2016
NIH/NCI
2016

NIH Merit Award 2017
NIH/NCI
2017

Best Use of Patient Engagement Technologies recognizes international partnerships in pharmaceutical, medical device and digital health innovation. Par
Prix Galien Medstart Up
2018

eCO App Development Group-in recognition of the development of the first oncology digital health technology platform for the risk-based patient manage
NIH/NCI Award of Merit
2019

Eligibility Criteria in Cancer Treatment Trials Group- in regocnition of outstanding leadership in the successful development and collaboration to bro
NIH/NCI Award of Merit
2019

Tirapine Clinical Development Group- in recognition of the successful clinical development of triapine, a ribonucleotide reductase inhibitor, in combi
NIH/NCI Award of Merit
2019

Academic Appointments
Last Updated 3/31/2021
George Washington University School Of Medicine And Health Sciences - Washington DC
Rank: Associate Professor
Years:


Rank: Associate Professor
Years: 1989-Present

Academic Appointments - Non-US
Last Updated 3/31/2021
None Reported
Publications
(up to ten in the last five years)
Last Updated 3/31/2021
Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints.
Expert Opin Investig Drugs
28:771–85
Date: 01 2019

Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
Cancer.
126:2139–45.
Date: 01 2020

Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors.
Cancer Chemother Pharmacol
86:535–45.
Date: 01 2020

Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
Clin Cancer Res.
26:5329–37.
Date: 01 2020

Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W.
J Clin Oncol.
38:2407–17.
Date: 01 2020

Quantitation of iohexol, a glomerular filtration marker, in human plasma by LC-MS/MS.
J Pharm Biomed Anal.
189:113464.
Date: 01 2020

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer
Ann Oncol.
31:590–8.
Date: 01 2020

Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment
Cancer Cell.
39:38–53.e7
Date: 01 2021

Phase 2 Study of Ibrutinib in Classic and Variant Hairy Cell Leukemia
Blood
blood.2020009688.
Date: 01 2021

The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study
J Natl Cancer Inst.
113:27–37
Date: 01 2021

Felony Conviction Information
Last Updated 3/31/2021
None Reported
Actions Taken by States/Organizations Other than the Virginia Board of Medicine
Last Updated 3/31/2021
None Reported
Virginia Board of Medicine Notices and Orders
Verified by Board
No Notices or Orders on file

Paid Claims in the last ten years
Last Updated 3/31/2021
The licensee has reported the following paid claims in the past ten years:
None Reported

Return to Normal View
Date Printed: 6/11/2024

Virginia Board of Medicine 9960 Mayland Drive, Suite 300, Henrico, VA 23233-1463